In particular, triple-negative breast cancer (TNBC, negative for estrogen receptor ER, progesterone receptor PR and human epidermal growth factor receptor 2 HER2) and basal-like breast cancer (mostly negative for ER, PR and HER2 with expression of basal markers), are the most aggressive subtypes of breast cancer. Here, ESR1 is linked to breast carcinoma.